bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report) shares hit a new 52-week high on Tuesday . The stock traded as high as $123.44 and last traded at $120.45, with a volume of 38 shares traded. The stock had previously closed at $120.00.
bioMérieux Trading Up 0.4 %
The company has a debt-to-equity ratio of 0.10, a current ratio of 2.21 and a quick ratio of 1.20. The firm’s 50-day moving average is $107.76 and its two-hundred day moving average is $110.31.
About bioMérieux
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
See Also
- Five stocks we like better than bioMérieux
- What is the S&P/TSX Index?
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- What is the Australian Securities Exchange (ASX)
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Comparing and Trading High PE Ratio Stocks
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.
